In a report, which will be launched by the UK's Minister for Science, Research & Innovation, experts have called on Government to turbocharge UK cannabinoid innovation as they claim it has – so far – taken a “disinterested” attitude to the sector.
List view / Grid view
Association for the Cannabinoid Industry (ACI)
Following on from the FSA’s update to its public CBD list which saw 1,700 new products added, New Food spoke to Paul Tossell of the FSA and Dr Paul Duffy of ACI to shed a little light on the decisions made so far and next steps.
Following two years of close collaboration between the Food Standards Agency and ACI, the initial list of permitted UK CBD products has been released. But there’s still more hurdles to come, and what does this mean for those that didn’t make the cut?
Dr Robert Verkerk, Dr Parveen Bhatarah and Dr Ignazio Garaguso explore the future of CBD and other non-psychotropic cannabinoids and cannabimimetics.
The cannabis arena is a lucrative market if you have the right tools and know-how; this month tune in to hear from three experts on how to successfully navigate this sector.
The CBD update from the FSA means the deadline is now for submission by 31 March 2021 and not validation.
The ACI has launched a pioneering consortia study that will address data gaps associated with the safety of CBD, ensuring that only safe and fully-compliant products are on the UK market by next spring.